Paragon 28 Inc. (FNA): Broker Consensus Forecast

This daily price chart for Paragon 28, Inc. (FNA) on the GURU.Markets platform captures the 13.01 metric. The business is based on the automated production of foot and ankle instruments and implants using CNC machining. However, potential raw material supply chain disruptions or operational insurance issues create certain risks. The company is currently scaling aggressively, regularly integrating advanced bone fixation methods into its portfolio.

Price Target Chart: Paragon 28 Corp (FNA) for 07/04/2022 - 04/26/2025

Analytical breakdowns for Paragon 28, Inc. (FNA)

- share price and expert price forecast:

Quote Chart paragon28.com|FNA - Price Target Chart

- stock exchange capitalization data:

Market Capitalization Paragon 28 Corp|FNA - Enterprise Value

- business book valuation details:

Book Value per Share Paragon 28|FNA - Company Book Value|Market Capitalization to Book Value paragon28.com|FNA - Aggregate Company Assets

- debt obligations and liquidity statistics:

- company profitability and valuation multiples indicators:

FNA - Company Net Income|Expected Profit Paragon 28, Inc.|FNA - P/E Multiple|Market Cap to Projected Earnings paragon28.com|FNA - Price/Earnings to Growth Multiple|Company Value to Operating Income Before Depreciation Ratio Paragon 28 Corp|FNA - Operating profit EBITDA|Net earnings per one share for the last twelve months Paragon 28|FNA - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months paragon28.com|FNA - Net earnings per share growth this year|Expected earnings per share trend next year Paragon 28, Inc.

General company analysis:FNA (Paragon 28 Inc.)

To identify the fundamental leaders of the sector, it is essential to track the dynamics of average investment bank price targets, which capture shifts in institutional sentiment through an aggregated asset valuation forecast. The rise in the consensus target for Paragon 28, Inc. (FNA) reflects analysts' confidence in the company's capitalization, bolstered by high surgeon loyalty to specialized implants, which ensures a steady stream of marginal revenue.

Competing companies